Related Experiment Video
Updated: Aug 9, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
Wei Xie1, Peng Jiang, Lin Miao
1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China Hefei, Anhui, 230027, China.
Abstract:
Deregulated expression of E2F1 not only promotes S-phase entry but also induces apoptosis. Although it has been well documented that E2F1 is able to induce p53-dependent apoptosis via raising ARF activity, the mechanism by which E2F induces p53-independent apoptosis remains unclear. Here we report that E2F1 can directly bind to and activate the promoter of Smac/DIABLO, a mitochondrial proapoptotic gene, through the E2F1-binding sites BS2 (-542 approximately -535 bp) and BS3 (-200 approximately -193 bp). BS2 and BS3 appear to be utilized in combination rather than singly by E2F1 in activation of Smac/DIABLO. Activation of BS2 and BS3 are E2F1-specific, since neither E2F2 nor E2F3 is able to activate BS2 or BS3. Using the H1299 ER-E2F1 cell line where E2F1 activity can be conditionally induced, E2F1 has been shown to upregulate the Smac/DIABLO expression at both mRNA and protein levels upon 4-hydroxytamoxifen treatment, resulting in an enhanced mitochondria-mediated apoptosis. Reversely, reducing the Smac/DIABLO expression by RNA interference significantly diminishes apoptosis induced by E2F1. These results may suggest a novel mechanism by which E2F1 promotes p53-independent apoptosis through directly regulating its downstream mitochondrial apoptosis-inducing factors, such as Smac/DIABLO.
Insights
The transcription factor E2F1 directly activates the Smac/DIABLO gene promoter, initiating p53-independent apoptosis. This mechanism involves E2F1 binding to specific sites, upregulating Smac/DIABLO, and enhancing mitochondrial apoptosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- E2F1 promotes cell cycle progression and apoptosis.
- E2F1-induced apoptosis is typically p53-dependent via ARF.
- The mechanism of E2F1-induced p53-independent apoptosis is not fully understood.
Purpose of the Study:
- To elucidate the mechanism of E2F1-induced p53-independent apoptosis.
- To investigate the direct regulation of proapoptotic genes by E2F1.
- To identify novel downstream targets of E2F1 in apoptosis.
Main Methods:
- Analysis of E2F1 binding to the Smac/DIABLO promoter using E2F1-binding sites (BS2, BS3).
- Conditional induction of E2F1 activity in H1299 ER-E2F1 cells.
- Assessment of Smac/DIABLO mRNA and protein levels.
- RNA interference to reduce Smac/DIABLO expression.
- Measurement of mitochondria-mediated apoptosis.
Main Results:
- E2F1 directly binds and activates the Smac/DIABLO promoter at BS2 and BS3 sites.
- E2F1 specifically activates these sites, unlike E2F2 or E2F3.
- E2F1 upregulates Smac/DIABLO expression, leading to enhanced mitochondria-mediated apoptosis.
- Reducing Smac/DIABLO expression significantly diminishes E2F1-induced apoptosis.
Conclusions:
- E2F1 directly regulates Smac/DIABLO, a key factor in mitochondrial apoptosis.
- This represents a novel p53-independent pathway for E2F1-mediated apoptosis.
- E2F1's role in apoptosis extends beyond p53-dependent pathways through direct regulation of mitochondrial factors.
Related Concept Videos
Cell Specific Gene Expression
Master Transcription Regulators
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
